epoprostenol

CHEBI:CHEBI_749266

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
EPOPROSTENOL
rxcui
1302755
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
route
INTRAVENOUS
marketing_start_date
20210116
nui
M0017817
pharm_class_pe
Vasodilation [PE]
pharm_class
Prostaglandins I [CS]
labeler_name
Wasserburger Arzneimittelwerk GmbH
manufacturer_name
Actelion Pharmaceuticals US, Inc.
package_marketing_start_date
20210116
active_ingredient_strength
.5 mg/10mL
active_ingredient_name
EPOPROSTENOL
pharm_class_epc
Prostacycline Vasodilator [EPC]
pharm_class_cs
Prostaglandins I [CS]
brand_name
EPOPROSTENOL
brand_name_base
EPOPROSTENOL
product_ndc
62756-059
application_number
ANDA213913
spl_id
2a163b77-9e01-4516-b19c-f5a12ce48560
package_ndc
62756-059-40
package_description
1 VIAL in 1 CARTON (62756-059-40) / 10 mL in 1 VIAL
unii
4K04IQ1OF4
spl_set_id
2a163b77-9e01-4516-b19c-f5a12ce48560
upc
0367457587103
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class